The University of Barcelona Science Park reaches a new investment record of €230 million ... 16/06/2026 Healthcare Innovative drugs Financing The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of... Partners - Parc Científic de Barcelona
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Thera... 16/06/2026 Healthcare Rare diseases Innovative drugs Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake... Partners - Gate2Brain
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Cl... 15/06/2026 Healthcare Innovative drugs International Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada, Australia and New... Partners - STABLEPHARMA
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia ... 11/06/2026 Healthcare Drug discovery Innovative drugs In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity... Partners - Oryzon Genomics
VIVEbiotech adds newest in vivo lentiviral vector-based therapeutic programs 10/06/2026 Healthcare Innovative drugs Advanced therapies Now advancing 15 next-generation in vivo therapies through high performance, scalable lentiviral vector manufacturing... Partners - VIVEbiotech
BCN HEALTH publishes a study evaluating the incidence and medical cost associated to intra... 03/06/2026 Healthcare Innovative drugs Personalized medicine Partners - BCN Health
ORYZON initiates patient enrollment in IDEAL Phase II trial of iadademstat in essential t... 02/06/2026 Healthcare Drug discovery Innovative drugs Oryzon Genomics, a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the... Partners - Oryzon Genomics
BioClonal seeks strategic partnerships to advance its Alzheimer’s antibody program and ant... 02/06/2026 Healthcare Access to innovation Drug discovery Innovative drugs Spanish biotechnology company BioClonal is advancing a proprietary monoclonal antibody program targeting a novel... Partners - BIOCLONAL
World Multiple Sclerosis Day | “Biotechnology is enabling progress toward a better underst... 29/05/2026 Healthcare Innovative drugs Personalized medicine On the occasion of World Multiple Sclerosis Day, we interviewed Sanofi, which has a research line specifically focused... AseBio - SANOFI
Beyond Evidence: The Challenge of Communicating Value in Biotechnology 27/05/2026 Healthcare Access to innovation Innovative drugs Spain is already generating science and innovation in biotechnology. The next challenge is not to produce more evidence... Partners - ProductLife Group
